Searched for
MULTIPLE SCLEROSIS DRUG
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- US Stocks: Apellis shares double on Biogen's $5.6 billion buyout planBiogen will buy Apellis Pharmaceuticals for about $5.6 billion, adding a promising kidney disease drug to broaden its rare-disease portfoli...
- Lupin gets USFDA nod for multiple sclerosis drugDrug maker Lupin has secured approval from the US health regulator for its generic multiple sclerosis treatment. The company received tenta...
- Zydus ties up with Synthon BV for multiple sclerosis drug launch in USZydus Lifesciences will launch a generic drug for multiple sclerosis in the United States. This is through a partnership with Synthon BV. T...
- Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
- Zydus receives USFDA Orphan Drug Designation for Usnoflast to treat ALSZydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for treating amyotr...
- Roche Pharma launches multiple sclerosis treatment drug in IndiaThe company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remittin...
- Scientists discover a genetic variant linked to severity of multiple sclerosisScientists have identified a genetic variant that is linked to the severity of multiple sclerosis (MS) and the progression of the disease o...
- Zydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drugDrug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- World Multiple Sclerosis Day: Don't struggle with everyday challenges, treatments can help manage the conditionMS is a chronic neurodegenerative condition that affects the central nervous system.
- Shilpa Medicare gets tentative USFDA nod for multiple sclerosis drugThe company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg ...
- Glenmark gets USFDA nod for multiple sclerosis medicationThe approved product is generic version of Sanofi-Aventis US' Aubagio.
- Sun Pharma settles patent litigation with Acorda TherapeuticsSun Pharma has settled patent litigation with Acorda Therapeutics over Ampyra extended-release tablets, which is used in the treatment of m...
- Biogen Idec gets DCGI nod for multiple sclerosis oral drugThe company has received approval for the first oral therapy drug Tecfidera for multiple sclerosis by DCGI, Biogen Idec Biotech India Pvt L...
- Natco set for US launch of generic copy of Teva’s drugIf the Hyderabad-based company begins selling the drug now, it may face penal damages on losing the patent battle with Teva.
- Natco Pharma up 20%, hits 52-week high on favourable ruling on Copaxone in USNatco Pharma was locked in at upper circuit at Rs 588.10, up 20 per cent. The stock hit a low of Rs 540 in trade today.
- Natco Pharma gets favourable ruling for generic Copaxone in USNatco Pharma on Saturday said it has obtained a favourable ruling from a US Court that paves way for launch of generic Copaxone.
- Heard on the Street: Fund stocks up Biocon on drug launch buzzA large fund house belonging to a business conglomerate has been accumulating biotechnology company Biocon over the past two weeks on drug ...
- Natco Pharma soars on drug licensing dealNatco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...
Load More
